GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Restart Life Sciences Corp (XCNQ:HEAL) » Definitions » Cash Flow from Others

Restart Life Sciences (XCNQ:HEAL) Cash Flow from Others : C$-0.58 Mil (TTM As of Dec. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Restart Life Sciences Cash Flow from Others?

Restart Life Sciences's cash flow from others for the three months ended in Dec. 2024 was C$-0.00 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2024 was C$-0.58 Mil.


Restart Life Sciences Cash Flow from Others Historical Data

The historical data trend for Restart Life Sciences's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Restart Life Sciences Cash Flow from Others Chart

Restart Life Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Others
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.78 -0.25 -0.07 0.08 -0.61

Restart Life Sciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -0.58 -

Restart Life Sciences Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.58 Mil.

Restart Life Sciences Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Restart Life Sciences's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Restart Life Sciences Business Description

Traded in Other Exchanges
Address
700-838 West Hastings St, Vancouver, BC, CAN, V6C 0A6
Restart Life Sciences Corp is a Canadian life sciences company dedicated to addressing today's health challenges with wellness solutions. It is focus is on creating health foods that address the needs of this community. Its Flagship developments includes Autism Spectrum, Health-Related Foods, Psilocybin Clinical Trial for Fragile X Syndrome, Orphan Drug Designation (FDA and EMA).
Executives
Derek Lloyd Harry Ivany 10% Security Holder, Director, Senior Officer
Steven Feldman Director
William Rascan Director, Senior Officer

Restart Life Sciences Headlines

No Headlines